European Union; Cancer Research UK; Bayer Corporation; National Starch and Chemical Co; UK Medical Research Council; Newcastle Hospitals trustees; Cancer Council of Victoria Australia; THRIPP South Africa; The Finnish Cancer Foundation; SIAK Switzerland; Bayer Pharma.
2011-12-19

Eng.
Lancet
Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK. john.burn [at] ncl.ac.uk
Lancet. 2011 Dec;378(9809):2081-7
© Galenicom 1999-2013